← Bausch & Lomb Corp
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Depreciation and amortization of intangible assets | $442.0m | $415.0m | $379.0m | $382.0m | $436.0m | $421.0m | |
| Amortization and write-off of debt premiums, discounts and issuance costs | $0 | $0 | $8.0m | $30.0m | $20.0m | $18.0m | |
| Amortization of inventory step-up resulting from acquisitions | — | — | — | $23.0m | $82.0m | $62.0m | |
| Deferred income taxes | $97.0m | $116.0m | ($90.0m) | ($10.0m) | ($10.0m) | ($32.0m) | |
| Asset impairments | $1.0m | $12.0m | $1.0m | $0 | $5.0m | $0 | |
| Share-based compensation | $50.0m | $62.0m | $62.0m | $74.0m | $92.0m | $149.0m | |
| Payment of employee withholding taxes related to share-based awards | — | $0 | $0 | ($10.0m) | ($12.0m) | ($15.0m) | |
| Loss on extinguishment of debt | — | — | — | $0 | $0 | $6.0m | |
| Net loss | ($17.0m) | $193.0m | $15.0m | ($248.0m) | ($305.0m) | ($352.0m) | |
| Acquisition-related contingent consideration | — | — | — | $2.0m | ($9.0m) | ($27.0m) | |
| Allowances for losses on trade receivables and inventories | $30.0m | $37.0m | $25.0m | $21.0m | $26.0m | $31.0m | |
| Gain on sale of assets | — | — | $0 | $0 | ($5.0m) | ($6.0m) | |
| Foreign exchange gain | ($19.0m) | $12.0m | ($7.0m) | $12.0m | $10.0m | $2.0m | |
| Gain excluded from hedge effectiveness | $0 | $0 | ($6.0m) | ($13.0m) | ($13.0m) | ($10.0m) | |
| Other | $3.0m | ($1.0m) | ($19.0m) | ($2.0m) | ($1.0m) | $0 | |
| Trade receivables | $77.0m | ($107.0m) | ($95.0m) | ($121.0m) | ($227.0m) | ($148.0m) | |
| Inventories | ($32.0m) | ($15.0m) | ($106.0m) | ($264.0m) | ($147.0m) | $38.0m | |
| Prepaid expenses and other current assets | $40.0m | ($13.0m) | ($7.0m) | ($147.0m) | $161.0m | $20.0m | |
| Accounts payable, accrued and other liabilities | ($144.0m) | $163.0m | $189.0m | $245.0m | $126.0m | $108.0m | |
| Acquisitions and other investments | $0 | $0 | ($45.0m) | ($1.9b) | ($138.0m) | ($122.0m) | |
| Purchases of marketable securities | ($6.0m) | ($19.0m) | ($17.0m) | ($17.0m) | ($12.0m) | ($11.0m) | |
| Proceeds from sale of marketable securities | $9.0m | $14.0m | $22.0m | $16.0m | $14.0m | $8.0m | |
| Proceeds from sale of assets and businesses, net of costs to sell | — | $0 | $0 | $1.0m | $2.0m | $7.0m | |
| Interest settlements from cross-currency swaps | — | $0 | $0 | $13.0m | $13.0m | $12.0m | |
| Payments of financing costs | $0 | $0 | ($3.0m) | ($16.0m) | $0 | ($12.0m) | |
| Accrued purchases of property, plant and equipment | — | $31.0m | $38.0m | $65.0m | $56.0m | $51.0m | |
| Net cash provided by (used in) operating activities | $522.0m | $873.0m | $345.0m | ($17.0m) | $232.0m | $283.0m | |
| Purchases of property, plant and equipment | ($253.0m) | ($193.0m) | ($175.0m) | ($181.0m) | ($291.0m) | ($349.0m) | |
| Net cash used in investing activities | ($256.0m) | ($214.0m) | ($215.0m) | ($2.1b) | ($412.0m) | ($455.0m) | |
| Issuance of long-term debt, net of discounts, and other financial liabilities | $0 | $0 | $2.4b | $2.3b | $631.0m | $3.4b | |
| Repayments of debt | $0 | $0 | ($13.0m) | ($161.0m) | ($430.0m) | ($3.1b) | |
| Payments of noncontrolling interest distributions | ($7.0m) | ($10.0m) | ($11.0m) | ($9.0m) | ($10.0m) | ($9.0m) | |
| Net cash provided by financing activities | ($232.0m) | ($712.0m) | $81.0m | $2.1b | $178.0m | $225.0m | |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | $12.0m | ($8.0m) | ($8.0m) | $2.0m | ($16.0m) | $28.0m | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | $46.0m | ($61.0m) | $203.0m | ($46.0m) | ($18.0m) | $81.0m | |
| Cash and cash equivalents and restricted cash, beginning of period | $238.0m | $177.0m | $380.0m | $334.0m | $316.0m | $397.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.